Shp1 phosphatase regulates CXCR2 protein stability and IL8-mediated invasiveness in breast cancer

Marcello Monti1, Pier Giorgio Amendola2, Angela Filograna1

  • 1Institute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore", National Research Council, Naples, Italy.

Cell Death & Disease
|March 2, 2026
PubMed

Insights

Inhibiting Shp1 phosphatase in breast cancer accelerates cell migration and invasiveness. Interleukin-8 (IL8) reduces Shp1 activity, impacting receptor turnover and promoting metastasis, especially in triple-negative breast cancer (TNBC).

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Shp1 phosphatase typically inhibits tumor growth by suppressing tyrosine kinase signaling.
  • Interleukin-8 (IL8) is a chemokine implicated in promoting tumor progression within the tumor microenvironment.
  • IL8 exerts its pro-tumorigenic effects via the CXCR2 receptor, influencing intracellular signaling pathways.

Purpose of the Study:

  • To investigate the role of Shp1 in breast cancer cell migration and invasiveness.
  • To elucidate the mechanism by which IL8 modulates Shp1 activity.
  • To identify Shp1 as a potential therapeutic target in aggressive breast cancer subtypes.

Main Methods:

  • Genetic and pharmacological inhibition of Shp1 in breast cancer cell lines (MCF7).
  • Analysis of IL8-induced signaling pathways, including PKC-mediated phosphorylation of Shp1 and CXCR2.
  • Assessment of receptor ubiquitination, degradation, and cell invasiveness.
  • Transcriptomic and pathway analyses.

Main Results:

  • Shp1 inhibition enhances breast cancer cell migration and invasiveness.
  • IL8 directly reduces Shp1 enzymatic activity through PKC-mediated phosphorylation at Ser591.
  • This interaction leads to enhanced CXCR2 phosphorylation, ubiquitination, and degradation, creating a feedback loop for signal attenuation.
  • Shp1's regulation of CXCR2 impacts IL8-driven invasiveness in a subtype-specific manner, notably affecting luminal and TNBC cells.
  • Shp1 downregulation correlates with reduced survival and elevated IL8 levels in TNBC.

Conclusions:

  • Shp1 plays a critical role in regulating IL8 signaling and breast cancer cell invasiveness.
  • A novel feedback mechanism involving Shp1, IL8, and CXCR2 turnover has been identified.
  • Targeting the CXCR2-Shp1 axis presents a promising therapeutic strategy for limiting invasiveness and metastasis in aggressive breast cancers, particularly TNBC.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K